Search research articles
Contact Us
Filters
Showing results (161-170 of 176) with videos related to
Page
of 18
Sort By:
American Journal of Respiratory and Critical Care Medicine
|
April 5, 2022
Ambient Air Pollution and Dysanapsis: Associations with Lung Function and Chronic Obstructive Pulmonary Disease in the Canadian Cohort Obstructive Lung Disease Study
Jean Bourbeau, Dany Doiron, Sharmistha Biswas, et al.
Plos One
|
November 19, 2016
Findings on Thoracic Computed Tomography Scans and Respiratory Outcomes in Persons with and without Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study
Wan C Tan, Cameron J Hague, Jonathon Leipsic, et al.
The European Respiratory Journal
|
January 28, 2012
Randomised controlled trial for emphysema with a selective agonist of the γ-type retinoic acid receptor
Jan Stolk, Robert A Stockley, Berend C Stoel, et al.
Archivos De Bronconeumologia
|
July 27, 2024
Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry
Hilal Ersöz, María Torres-Durán, Alice M Turner, et al.
ERJ Open Research
|
February 11, 2026
Characteristics of bronchiectasis in patients with different genotypes of severe α<sub>1</sub>-antitrypsin deficiency from the EARCO registry
Francesca Mandurino Mirizzi, Cristina Aljama, Pierachille Santus, et al.
Archivos De Bronconeumologia
|
January 23, 2026
Routine Blood Biomarkers in Patients With the PI*SZ Genotype of Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry
Ane Lopez-Gonzalez, Robson Aparecido Prudente, Cristina Aljama, et al.
The Lancet. Respiratory Medicine
|
December 6, 2016
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)
Noel G McElvaney, Jonathan Burdon, Mark Holmes, et al.
The Lancet. Respiratory Medicine
|
October 1, 2021
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study
Michael E Wechsler, Linda B Ford, Jorge F Maspero, et al.
The European Respiratory Journal
|
September 18, 2025
Two randomised controlled phase 2 studies of the oral neutrophil elastase inhibitor alvelestat in alpha-1 antitrypsin deficiency
J Michael Wells, Ingrid L Titlestad, Hanan Tanash, et al.
Allergy
|
June 26, 2024
Real-world biologics response and super-response in the International Severe Asthma Registry cohort
Eve Denton, Mark Hew, Matthew J Peters, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 176) with videos related to
Sort By:
Page
of 18
American Journal of Respiratory and Critical Care Medicine
|
April 5, 2022
Ambient Air Pollution and Dysanapsis: Associations with Lung Function and Chronic Obstructive Pulmonary Disease in the Canadian Cohort Obstructive Lung Disease Study
Jean Bourbeau, Dany Doiron, Sharmistha Biswas, et al.
Plos One
|
November 19, 2016
Findings on Thoracic Computed Tomography Scans and Respiratory Outcomes in Persons with and without Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study
Wan C Tan, Cameron J Hague, Jonathon Leipsic, et al.
The European Respiratory Journal
|
January 28, 2012
Randomised controlled trial for emphysema with a selective agonist of the γ-type retinoic acid receptor
Jan Stolk, Robert A Stockley, Berend C Stoel, et al.
Archivos De Bronconeumologia
|
July 27, 2024
Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry
Hilal Ersöz, María Torres-Durán, Alice M Turner, et al.
ERJ Open Research
|
February 11, 2026
Characteristics of bronchiectasis in patients with different genotypes of severe α<sub>1</sub>-antitrypsin deficiency from the EARCO registry
Francesca Mandurino Mirizzi, Cristina Aljama, Pierachille Santus, et al.
Archivos De Bronconeumologia
|
January 23, 2026
Routine Blood Biomarkers in Patients With the PI*SZ Genotype of Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry
Ane Lopez-Gonzalez, Robson Aparecido Prudente, Cristina Aljama, et al.
The Lancet. Respiratory Medicine
|
December 6, 2016
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)
Noel G McElvaney, Jonathan Burdon, Mark Holmes, et al.
The Lancet. Respiratory Medicine
|
October 1, 2021
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study
Michael E Wechsler, Linda B Ford, Jorge F Maspero, et al.
The European Respiratory Journal
|
September 18, 2025
Two randomised controlled phase 2 studies of the oral neutrophil elastase inhibitor alvelestat in alpha-1 antitrypsin deficiency
J Michael Wells, Ingrid L Titlestad, Hanan Tanash, et al.
Allergy
|
June 26, 2024
Real-world biologics response and super-response in the International Severe Asthma Registry cohort
Eve Denton, Mark Hew, Matthew J Peters, et al.
Page
of 18